• News

"Mount Sinai’s New Research Center Focuses on AI — Here’s What that Means for Clinical Trials" - Bruce Gould

  • MD Connect
  • New York, NY
  • (July 10, 2019)

The Icahn School of Medicine at Mount Sinai has announced plans to launch a new center for AI research in 2021. The Hamilton and Amabel James Center for Artificial Intelligence and Human Health will focus on genomics, disease modeling, imaging technology, and prediction of novel therapies. “We see the potential of artificial intelligence to radically transform the care that patients receive, and we want to shape and lead this effort,” said Kenneth Davis, MD, CEO and president of the Mount Sinai Health System. Mount Sinai’s investment and similar initiatives undertaken by other healthcare leaders are likely to accelerate the adoption of AI in clinical trials.

— Kenneth L. Davis, MD, CEO, President, Mount Sinai Health System


Learn more